With the approval of several new gene/vector therapies and many more on the horizon, our institution is planning to develop policies and procedures to standardize our approach to storage, preparation, administration, decontamination, and disposal of gene/vector therapies.

Does your institution have standardized policies or procedures in place related to gene/vector therapies that you could share? For institutions utilizing Epic EMR, do you utilize any Epic functionality in the EMR to alert staff that a patient is receiving or has received gene/vector therapy?

We currently use the same concentration but displayed in different ways to accommodate both pediatric and adult dosing units.

Bumetanide 250 mcg/ml in pediatric patients (dosed in mcg/kg/hr) and 0.25 mg/ml in adult patients (dosed in mg/hr).
Amiodarone 1,800 mcg/ml in pediatric patients (dosed in mcg/kg/min) and 1.8 mg/ml (dosed in mg/min).

We are wondering what others are doing. Do you use the same concentration for both peds and adults? If yes, have you had issues with converted from mcg dosing to mg or mg to mcg?

Hi,

We are working on developing processes/policies related to discharge medication calendars. We have criteria at our institution but are attempting to mitigate transcription error risk. Please reply to the below and if you do not complete medication calendars, that information is helpful as well and we would appreciate the quick “No” reply!

Thank you in advance for your responses and much valued time!

Hello!
We are a large pediatric hospital currently preparing for Alaris-Epic interoperability.

Looking for guidance in the following:
1. Recommendations or insight to make our process towards interoperability more successful
2. The biggest struggles you had with aligning Guardrails and Epic ERX records
3. How to increase interoperability compliance to 95%

Any and all advice is truly appreciated!
Thank you!

Hello, does anyone have information regarding ineffective rocuronium at their site?
Thank you

Now that the Waiver Elimination (MAT Act) eliminated the need for providers to obtain an X waiver to prescribe buprenorphine for opioid use disorder, my understanding is that buprenorphine should be like any other drug.

Does this mean that the 3-day rule for patients that present to a hospital for opioid withdrawal now applies only to methadone, but not to buprenorphine?

Have other organizations relaxed the rules for buprenorphine use, or do you have a different interpretation on how this legal change affects hospitals?

Good Morning,

Our health system currently uses the standard concentration for adult infusions recommended by the ASHP Standardize 4 Safety initiative of rocuronium 10 mg/mL (i.e., undiluted product). We have a physician that is questioning this concentration based on his interpretation of the package insert that states the diluted concentrations should be 0.5 mg/mL, 1 mg/mL, or 5 mg/mL. I am reaching out to see what other health systems are using as their standard concentration for adult infusions of rocuronium.

Thanks in advance!

Hi,

Has anyone been successful with anesthesiology barcode scanning medications prior to administration in the OR without use of a third party vendor (e.g. codonics)? We utilize Epic and Omnicell.
Thanks -
Maria Cumpston
West Virginia University Hospitals

Hello,

We're starting to see a few errors creep up relating to re-timing of medications. Currently nursing is responsible for retiming medications at our organization. In my previous organization, Pharmacy was responsible for retiming (and timing the first doses) of medications. We're considering whether we want to take on changing this workflow such that Pharmacy owns retiming.

Has anyone done this project to convert from nursing to pharmacy with who owns retiming med orders in your institution?

I welcome any comments, or recommendations.

Thanks!